Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma

Annals of Hematology

Volumn 81, Issue 9, 2002, Pages 535-537

  Trojan, A ^a   Meier, R ^a   Licht, A ^b   Taverna, C ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Stadtspital Triemli ^*  (Switzerland)

Author keywords

Acute eosinophilic pneumonia; Fludarabine; Follicular non Hodgkin's; Pulmonary toxicity

Indexed keywords

ANTHRACYCLINE; CHLORAMBUCIL; CYTOTOXIC AGENT; FLUDARABINE; PREDNISONE; PURINE DERIVATIVE; RITUXIMAB;

ADULT; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; COUGHING; DISEASE ASSOCIATION; DRUG EFFICACY; EOSINOPHILIA; FEMALE; FOLLICULAR LYMPHOMA; HEART FAILURE; HUMAN; LOEFFLER PNEUMONIA; LUNG DISEASE; LUNG LAVAGE; MEDICAL LITERATURE; MONOTHERAPY; NONHODGKIN LYMPHOMA; PATIENT CARE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; AORTIC VALVE STENOSIS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; LYMPHOMA, FOLLICULAR; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; PULMONARY EOSINOPHILIA; VIDARABINE;

EID: 0036935018     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0497-9     Document Type: Article

References (22)

1. Abid SH, Malhotra V, Perry MC (2001) Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 13:242-248
2. Angelopoulou MA, Poziopoulos C, Boussiotis VA, Kontopidou F, Pangalis GA (1996) Fludarabine monophosphate in refractory B-chronic lymphocytic leukemia: maintenance may be significant to sustain response. Leuk Lymphoma 21:321-324
3. Briasoulis E, Pavlidis N (2001) Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapy. Oncologist 6:153-161
4. Cervantes F, Salgado C, Montserrat E, Rozman C (1990) Fludarabine for prolymphocytic leukaemia and risk of interstitial pneumonitis. Lancet 336:1130
5. Federico M, Vitolo U, Zinzani PL, Chisesi T, Clo V, Bellesi G, Magagnoli M, Liberati M, Boccomini C, Niscola P, Pavone V, Cuneo A, Santini G, Brugiatelli M, Baldini L, Rigacci L, Resegotti L (2000) Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi. Blood 95:783-789
6. Hallek M, Schmitt B, Wilhelm M, Busch R, Krober A, Fostitsch HP, Sezer O, Herold M, Knauf W, Wendtner CM, Kuse R, Freund M, Franke A, Schriever F, Nerl C, Dohner H, Thiel E, Hiddemann W, Brittinger G, Emmerich B (2001) Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group. Br J Haematol 114:342-348
7. Hurst PG, Habib MP, Garewal H, Bluestein M, Paquin M, Greenberg BR (1987) Pulmonary toxicity associated with fludarabine monophosphate. Invest New Drugs 5:207-210
8. Imokawa S, Colby TV, Leslie KO, Helmers RA (2000) Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 15:373-381
9. Johnson S, Smith AG, Loffler H, Osby E, Juliusson G, Emmerich B, Wyld PJ, Hiddemann W (1996) Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL. Lancet 347:1432-1438
10. Kane GC, McMichael AJ, Patrick H, Erslev AJ (1992) Pulmonary toxicity and acute respiratory failure associated with fludarabine monophosphate. Respir Med 86:261-263
11. Keating MJ, O'Brien S, Lerner S, Koller C, Beran M, Robertson LE, Freireich EJ, Estey E, Kantarjian H (1998) Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood 92: 1165-1171
12. Khalil H, Molinary E, Stoller JK (1993) Diclofenac (Voltaren)-induced eosinophilic pneumonitis. Case report and review of the literature. Arch Intern Med 153:1649-1652
13. Larfars G, Uden-Blohme AM, Samuelsson J (1996) Fludarabine, as well as 2-chlorodeoxyadenosine, can induce eosinophilia during treatment of lymphoid malignancies. Br J Haematol 94:709-712
14. Lehne G, Lote K (1990) Pulmonary toxicity of cytotoxic and immunosuppressive agents. A review. Acta Oncol 29:113-124
15. Levin M, Aziz M, Opitz L (1997) Steroid-responsive interstitial pneumonitis after fludarabine therapy. Chest 111:1472-1473
16. Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD, Schiffer CA (2000) Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 343: 1750-1757
17. Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC (2000) Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 20:1245-1259
18. Schilling PJ, Vadhan-Raj S (1990) Concurrent cytomegalovirus and pneumocystis pneumonia after fludarabine therapy for chronic lymphocytic leukemia. N Engl J Med 323:833-834
19. Sezer O, Schmid P, Hallek M, Schweigert M, Beinert T, Langelotz C, Mergenthaler HG, Possinger K (1999) Eosinophilia during fludarabine treatment of chronic lymphocytic leukemia. Ann Hematol 78:475-477
20. Shintani H, Fujimura M, Yasui M, Ueda K, Kameda S, Noto M, Matsuda T, Kobayashi M (2000) Acute eosinophilic pneumonia caused by cigarette smoking. Intern Med 39:66-68
21. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G, Varadi G, Kirschbaum M, Ackerstein A, Samuel S, Amar A, Brautbar C, Ben Tal O, Eldor A, Or R (1998) Non-myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases. Blood 91:756-763
22. Solal-Celigny P, Brice P, Brousse N, Caspard H, Bastion Y, Haioun C, Bosly A, Tilly H, Bordessoule D, Sebban C, Harousseau JL, Morel P, Dupas B, Plassart F, Vasile N, Fort N, Leporrier M (1996) Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de I'Adulte. J Clin Oncol 14:514-519